Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated laboratory-treated autologous lymphocytes with aldesleukin and sargramostim (GM-CSF) for advanced solid tumors; the study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• Aldesleukin (interleukin-2)
• sargramostim (sargramostim)

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Neoplasms, Tumors | Phase 1 | Status: TERMINATED